;)
ArrePath will be presenting at the BioNJ BioPartnering event on May 14th at Liberty Science Center in Jersey City, NJ!
Join us in the Delta Lab at 10:50 AM – 12:10 PM.
The BioNJ BioPartnering Conference is co-sponsored by J.P. Morgan, J&J Innovation, and Morgan Lewis, and hosted by the Jersey City Economic Development Corporation.
ArrePath will be attending the 34th European Congress of Clinical Microbiology & Infectious Diseases, which will take place in Barcelona, Spain from April 27-30.
ArrePath is pleased to be presenting at @MassBio 2024 Align
Summit w/ insights by @McKinsey & @LocustWalkPtrs. Register for a day full of partnering opps. w/
investors, panels & presentations from early-stage #Biotech and emerging AI/ML companies.
https://www.massbio.org/align
ArrePath will be attending the 2024 Gordon Research Conference on New Antibacterial Discovery and Development, March 17-22, 2024, Ventura CA.
ArrePath will be attending the 8th AMR Conference, March 6-7, 2024 in Basel Switzerland.
Kurt Thorn, ArrePath’s Chief Technology Officer, will be speaking at the Biotech Showcase on January 9, 2024.
07-19-2023 
We look forward to the World AMR Conference September 7-8 in Philadelphia, where our CEO, Lloyd Payne will be attending.
ArrePath will be attending the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance happening on Sept. 19-22, 2023 in Boston, Mass. where you’ll hear the latest updates in drug development and antimicrobial resistance.
02-27-2023 
ArrePath will be attending the 7th AMR Conference, March 16-17, Basel, Switzerland, where our CEO, Lloyd Payne and founder Zemer Gitai will be attending.
01-27-2023 
ArrePath is looking forward to taking part in BioInfect 2023 on February 1, 2023